Skip to main content
Premium Trial:

Request an Annual Quote

BCW Index Up 5.3 Percent for First Quarter

The BCW Index rose 5.31 percent for the first quarter of 2006, with shares of 11 of the 16 firms in the Index increasing during the period. For the period from Jan. 3 to Apr. 4, the Index outgained the Nasdaq, which rose 4.53 percent for the same period; the Nasdaq Biotech Index, which gained 3.69 percent; and the Dow Jones Industrial Average, which increased 3.29 percent.

Thermo Electron led all gainers with a 22.06-percent rise in its shares. Other strong performers for the quarter included Qiagen, which gained 20.68 percent; Molecular Devices, which rose 19.23 percent; and Bruker BioSciences and Agilent, which both gained more than 13 percent.

The five firms to lose ground during the first quarter were Beckman Coulter, Bio-Rad Laboratories, General Electric, Harvard Bioscience, and PerkinElmer. Harvard Bio had the largest decline by far, falling 15.22 percent for the quarter.

File Attachments
The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.